CWA
WST icon

Clarus Wealth Advisors’s West Pharmaceutical WST Stock Holding History

Clarus Wealth Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-33
Closed -$4K – 553
2019
Q2 		$4K Hold
33
– – ﹤0.01% 527
2019
Q1 		$4K Hold
33
– – ﹤0.01% 619
2018
Q4 		$3K Hold
33
– – ﹤0.01% 631
2018
Q3 		$4K Sell
33
-24
-42% -$2.69K ﹤0.01% 642
2018
Q2 		$5K Buy
+57
New +$5.25K ﹤0.01% 627

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clarus Wealth Advisors's WST Position: Q3 2019 in Review

Clarus Wealth Advisors sold out of West Pharmaceutical (WST) in Q3 2019, closing a stake of 33 shares — an estimated $4K sold.

Clarus Wealth Advisors first reported a position in WST in Q2 2018 and held it in 5 quarters. The position peaked at $5K in Q2 2018. 406 funds tracked by Wall St. Rank hold WST as of Q3 2019.

  • Clarus Wealth Advisors reported no remaining West Pharmaceutical position as of Q3 2019 after selling out during the quarter.
  • Clarus Wealth Advisors sold 33 West Pharmaceutical shares in Q3 2019, an estimated $4K.
  • Clarus Wealth Advisors first reported a position in West Pharmaceutical in Q2 2018 and held it in 5 quarters.
  • Clarus Wealth Advisors's West Pharmaceutical position peaked at $5K in Q2 2018.
  • 406 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2019.

Based on Clarus Wealth Advisors's 13F filing for Q3 2019, filed 11 Oct 2019.